Open Label, Randomized Multicentre Phase II/III Study of Docetaxel in Combination With Cisplatin (CDDP) or Docetaxel in Combination With 5-Fluorouracil (5-FU) and CDDP Compared to the Combination of CDDP and 5-FU in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease.
Phase of Trial: Phase II/III
Latest Information Update: 12 May 2009
At a glance
- Drugs Cisplatin; Docetaxel; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 01 Aug 2007 Results have been published.
- 01 Nov 2006 Primary endpoint 'Time to disease progression' has been met.
- 19 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History